These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23414136)

  • 21. Bitter gourd (Momordica Charantia): A dietary approach to hyperglycemia.
    Krawinkel MB; Keding GB
    Nutr Rev; 2006 Jul; 64(7 Pt 1):331-7. PubMed ID: 16910221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Momordica charantia Administration Improves Insulin Secretion in Type 2 Diabetes Mellitus.
    Cortez-Navarrete M; Martínez-Abundis E; Pérez-Rubio KG; González-Ortiz M; Méndez-Del Villar M
    J Med Food; 2018 Jul; 21(7):672-677. PubMed ID: 29431598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complementary and comparative study on hypoglycemic and antihyperglycemic activity of various extracts of Eugenia jambolana seed, Momordica charantia fruits, Gymnema sylvestre, and Trigonella foenum graecum seeds in rats.
    Yadav M; Lavania A; Tomar R; Prasad GB; Jain S; Yadav H
    Appl Biochem Biotechnol; 2010 Apr; 160(8):2388-400. PubMed ID: 19904502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The soybean peptide aglycin regulates glucose homeostasis in type 2 diabetic mice via IR/IRS1 pathway.
    Lu J; Zeng Y; Hou W; Zhang S; Li L; Luo X; Xi W; Chen Z; Xiang M
    J Nutr Biochem; 2012 Nov; 23(11):1449-57. PubMed ID: 22278080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antioxidant properties of Momordica Charantia (bitter gourd) seeds on Streptozotocin induced diabetic rats.
    Sathishsekar D; Subramanian S
    Asia Pac J Clin Nutr; 2005; 14(2):153-8. PubMed ID: 15927932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Momordica charantia (bitter melon) reduces plasma apolipoprotein B-100 and increases hepatic insulin receptor substrate and phosphoinositide-3 kinase interactions.
    Nerurkar PV; Lee YK; Motosue M; Adeli K; Nerurkar VR
    Br J Nutr; 2008 Oct; 100(4):751-9. PubMed ID: 18321395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging Trends On Drug Delivery Strategy of Momordica charantia against Diabetes and its Complications.
    Thent ZC; Das S; Zaidun NH
    Curr Drug Deliv; 2018; 15(4):453-460. PubMed ID: 28545355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of experimental diabetic cataract by Indian Ayurvedic plant extracts.
    Rathi SS; Grover JK; Vikrant V; Biswas NR
    Phytother Res; 2002 Dec; 16(8):774-7. PubMed ID: 12458487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoglycaemic and hypotensive effects of Momordica charantia Linn (Cucurbitaceae) whole-plant aqueous extract in rats.
    Ojewole JA; Adewole SO; Olayiwola G
    Cardiovasc J S Afr; 2006; 17(5):227-32. PubMed ID: 17117226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Momordica charantia on lipid profile and oral glucose tolerance in diabetic rats.
    Chaturvedi P; George S; Milinganyo M; Tripathi YB
    Phytother Res; 2004 Nov; 18(11):954-6. PubMed ID: 15597317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A cell-based screening identifies compounds from the stem of Momordica charantia that overcome insulin resistance and activate AMP-activated protein kinase.
    Cheng HL; Huang HK; Chang CI; Tsai CP; Chou CH
    J Agric Food Chem; 2008 Aug; 56(16):6835-43. PubMed ID: 18656931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Water extracts from Momordica charantia increase glucose uptake and adiponectin secretion in 3T3-L1 adipose cells.
    Roffey BW; Atwal AS; Johns T; Kubow S
    J Ethnopharmacol; 2007 May; 112(1):77-84. PubMed ID: 17363205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Some toxicological studies of Momordica charantia L. on albino rats in normal and alloxan diabetic rats.
    Abd El Sattar El Batran S; El-Gengaihi SE; El Shabrawy OA
    J Ethnopharmacol; 2006 Nov; 108(2):236-42. PubMed ID: 16815658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GLP-I secretion in healthy and diabetic Wistar rats in response to aqueous extract of Momordica charantia.
    Bhat GA; Khan HA; Alhomida AS; Sharma P; Singh R; Paray BA
    BMC Complement Altern Med; 2018 May; 18(1):162. PubMed ID: 29776414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Steam-dried ginseng berry fermented with Lactobacillus plantarum controls the increase of blood glucose and body weight in type 2 obese diabetic db/db mice.
    Kim ST; Kim HB; Lee KH; Choi YR; Kim HJ; Shin IS; Gyoung YS; Joo SS
    J Agric Food Chem; 2012 May; 60(21):5438-45. PubMed ID: 22563735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Saponins from the traditional medicinal plant Momordica charantia stimulate insulin secretion in vitro.
    Keller AC; Ma J; Kavalier A; He K; Brillantes AM; Kennelly EJ
    Phytomedicine; 2011 Dec; 19(1):32-7. PubMed ID: 22133295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene cloning and expression of a novel hypoglycaemic peptide from Momordica charantia.
    Wang BL; Zhang WJ; Zhao J; Wang FJ; Fan LQ; Wu YX; Hu ZB
    J Sci Food Agric; 2011 Oct; 91(13):2443-8. PubMed ID: 21626510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerasee, a traditional treatment for diabetes. Studies in normal and streptozotocin diabetic mice.
    Bailey CJ; Day C; Turner SL; Leatherdale BA
    Diabetes Res; 1985 Mar; 2(2):81-4. PubMed ID: 3899464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antidiabetic activity of Momordica charantia seeds on streptozotocin induced diabetic rats.
    Sekar DS; Sivagnanam K; Subramanian S
    Pharmazie; 2005 May; 60(5):383-7. PubMed ID: 15918591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoglycemic action of borapetoside A from the plant Tinospora crispa in mice.
    Ruan CT; Lam SH; Lee SS; Su MJ
    Phytomedicine; 2013 Jun; 20(8-9):667-75. PubMed ID: 23523259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.